The global super absorbent dressings market size was US$ 95 million in 2021. The global super absorbent dressings market size is forecast to reach US$ 141 million by 2030, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period from 2022 to 2030.
Multi-layer wound materials containing a semi-adherent or non-adherent layer, as well as extremely absorbent layers of fibers like cotton, cellulose, or rayon, meant to minimize wound adherence and manage exudates, are known as super absorbent dressings. They can use on surgical wounds, burns, abrasions, lacerations, donor or skin graft sites, or any other oozing wound as a major or minor dressing. Super absorbent wound dressings, on the other hand, are critical in the treatment of chronic wounds. Large volumes of wound exudates from stress and vascular ulcers, burns, skin grafts, surgical incisions, and chronic wounds are rapidly absorbed by the extremely absorbent polymer dressing core.
Factors Influencing Market Growth
Impact Analysis of COVID-19
The COVID-19 pandemic had a negative impact on the global market. Several governments worldwide implemented a lockdown in order to prevent the spread of the virus. In addition, several hospitals and clinics were focusing on treating COVID-19 patients, and the fear of contracting the virus among people reduced the demand for super absorbent dressing.
Regional Analysis
North America garnered the major market revenue share in 2021 and is forecast to remain dominant during the forecast period. As a result of the rising R&D and many government initiatives to develop novel concepts. In addition, growing chronic wound prevalence, a surge in public awareness, the existence of a large aging population base, and an expansion of the patient pool in countries such as the United States. Thus, these factors fuel the market growth in the region.
Leading Competitors
The leading prominent companies profiled in the global super absorbent dressings market are:
Scope of the Report
The global super absorbent dressings market segmentation focuses on Product, Application, End-User, and Region.
Segmentation based on Product
Segmentation based on Application
Segmentation based on End-User
Segmentation based on Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL SUPER ABSORBENT DRESSINGS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL SUPER ABSORBENT DRESSINGS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL SUPER ABSORBENT DRESSINGS MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 ADHERENT
5.3 NON-ADHERENT
6 GLOBAL SUPER ABSORBENT DRESSINGS MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 CHRONIC WOUNDS
6.2.1 DIABETIC FOOT ULCERS
6.2.2 PRESSURE ULCERS
6.2.3 VENOUS LEG ULCERS
6.3 OTHER CHRONIC WOUNDS
6.3.1 ACUTE WOUNDS
6.3.2 SURGICAL & TRAUMATIC WOUNDS
6.3.3 BURNS
7 GLOBAL SUPER ABSORBENT DRESSINGS MARKET, BY END-USER
7.1 OVERVIEW
7.2 HOSPITALS
7.3 CLINICS
7.4 HOME HEALTHCARE
7.5 OTHERS
8 GLOBAL SUPER ABSORBENT DRESSINGS MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL SUPER ABSORBENT DRESSINGS MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
10 COMPANY PROFILES
10.1 3M HEALTHCARE
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.2 JOHNSON & JOHNSON
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.3 COLOPLAST CORP.
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.4 HARTMANN USA INCORPORATED
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.5 MOLNLYCKE HEALTH CARE AB
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.6 SMITH & NEPHEW
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.7 INTEGRA LIFESCIENCES
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.8 COVALON TECHNOLOGIES, LIMITED
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.9 MCKESSON CORPORATION
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.10 ADVANCIS MEDICAL
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.11 PAUL HARTMANN PTY LIMITED
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS
10.12 MEDLINE INDUSTRIES
10.12.1 OVERVIEW
10.12.2 FINANCIAL PERFORMANCE
10.12.3 PRODUCT OUTLOOK
10.12.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved